Literature DB >> 26232447

Positive voided urine cytology predicts worse pathological findings of nephroureterectomy specimens in patients with upper tract urothelial carcinoma: does selective ureteral cytology have an additional efficacy?

Shigeru Sakano1, Teruo Inamoto2, Ryo Inoue3, Hiroaki Matsumoto3, Kazuhiro Nagao3, Yoshiaki Yamamoto3, Haruhito Azuma2, Hideyasu Matsuyama3.   

Abstract

OBJECTIVE: After radical nephroureterectomy, substantial numbers of patients with upper tract urothelial carcinoma are ineligible for adjuvant chemotherapy owing to diminished renal function. Accurate pre-operative prediction of worse pathological findings in radical nephroureterectomy specimens can guide appropriate patient selection for neoadjuvant chemotherapy. Herein, we evaluated pre-operative voided urine cytology and the additional efficacy of selective ureteral cytology for predicting pathological features in upper tract urothelial carcinoma patients.
METHODS: This retrospective cohort study comprised 722 patients with upper tract urothelial carcinoma who underwent radical nephroureterectomy. Patients with concomitant bladder cancer and those who received neoadjuvant therapy were excluded. Finally, 437 patients with urinary cytology data were enrolled in the study. We assessed the positive voided urine and selective ureteral cytology for predicting higher pathological T stage (≥ pT3), higher tumor grade (3) and positive lymphovascular invasion.
RESULTS: Previous bladder cancer, tumor location, clinical T stage and voided urine cytology (P = 0.029) were independently associated with ≥ pT3, whereas selective ureteral cytology was not. Gender, clinical N category and voided urine cytology (P = 0.017) were independently associated with tumor Grade 3, whereas selective ureteral cytology was not. Hydronephrosis, clinical T stage, clinical N category and voided urine cytology (P = 0.0021) were independently associated with lymphovascular invasion, whereas selective ureteral cytology was not.
CONCLUSIONS: Pre-operative positive voided urine cytology was an independent predictor for worse pathological findings in radical nephroureterectomy specimens, while selective ureteral cytology had no additional efficacy. However, further studies with larger numbers of patients and complete data sets are needed to select patients for more aggressive treatments including neoadjuvant chemotherapy.
© The Author 2015. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  cytology; pathology; upper urinary tract; urothelial carcinoma

Mesh:

Year:  2015        PMID: 26232447     DOI: 10.1093/jjco/hyv114

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  4 in total

1.  The role of urinary cytology when diagnostic workup is suspicious for upper tract urothelial carcinoma but tumour biopsy is nonconfirmatory.

Authors:  David Horovitz; Yifan Meng; Jean V Joseph; Changyong Feng; Guan Wu; Hani Rashid; Edward M Messing
Journal:  Can Urol Assoc J       Date:  2017-07-11       Impact factor: 1.862

Review 2.  Perioperative chemotherapy in the management of high risk upper tract urothelial cancers.

Authors:  Matthew G Kaag
Journal:  Transl Androl Urol       Date:  2020-08

3.  Impact of Surgical Wait Time on Survival in Patients With Upper Urinary Tract Urothelial Carcinoma With Hydronephrosis.

Authors:  Fangzheng Zhao; Nienie Qi; Chu Zhang; Ning Xue; Shuaishuai Li; Raorao Zhou; Zeyu Chen; Ruiqin Yao; Haitao Zhu
Journal:  Front Oncol       Date:  2021-07-05       Impact factor: 6.244

4.  Clinical and prognostic value of preoperative hydronephrosis in upper tract urothelial carcinoma: a systematic review and meta-analysis.

Authors:  Yuejun Tian; Yuwen Gong; Yangyang Pang; Zhiping Wang; Mei Hong
Journal:  PeerJ       Date:  2016-06-21       Impact factor: 2.984

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.